Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-02-03 @ 9:40 AM
Study NCT ID:
NCT03664804
Status:
COMPLETED
Last Update Posted:
2025-01-03
First Post:
2018-09-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-09-07
First Submit QC Date:
None
Study First Post Date:
2018-09-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-04-11
Results First Submit QC Date:
None
Results First Post Date:
2025-01-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-14
Last Update Post Date:
2025-01-03
Last Update Post Date Type:
ACTUAL